Physician
Potomac Oncology & Hematology, LLC
Potomac Oncology & Hematology, LLC was paid $1.05M by Medicaid between Jan 2018 and Dec 2024, across 17 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 24% of everything it billed.
33Billing provider infoPOTOMAC ONCOLOGY & HEMATOLOGY, LLC
ROCKVILLE, MD 20852
ROCKVILLE, MD 20852
33aNPI1962947937assigned 12/30/2016
33bProvider typeHematology & Oncology Physician
28Total paid$1.05M
24GClaims33,895
24DCodes billed17
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Hematology & Oncology Physician providers in Maryland
Rank by total paid#5 of 30
Median peer was paid$116K
This provider vs. median9.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 102 | $1K | |
| 2019 | 1,025 | $13K | |
| 2020 | 3,780 | $102K | |
| 2021 | 6,077 | $174K | |
| 2022 | 7,337 | $211K | |
| 2023 | 9,805 | $348K | |
| 2024incomplete | 5,769 | $203K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 24% | 3,864 | 2,712 | $253K |
| 36415 | Collection of venous blood by venipuncture | 18% | 3,395 | 1,111 | $189K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 3,109 | 2,301 | $156K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 14% | 12,981 | 5,209 | $146K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 12% | 3,474 | 1,271 | $129K |
| 96367 | 8.8% | 1,968 | 470 | $93K | |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 4.4% | 796 | 199 | $46K |
| 99223 | Prolong inpt eval add15 m | 1.4% | 114 | 96 | $15K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 99 | 38 | $7K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 566 | 450 | $7K |
| J3490 | Unclassified drugs | <1% | 596 | 164 | $4K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 723 | 262 | $3K |
5 more codes
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 242 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 920 | $2K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 758 | $399.12 |
| S0028 | Injection, famotidine, 20 mg | <1% | 277 | $270.08 |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 13 | $153.36 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialXU, JAMES (PHYSICIAN-OWNER)